We are live on !
Find out more
Brandywine Managers Portfolio holdings
AUM
$202M
Turnover
13.04%
1-Year Est. Return
16.99%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+16.99%
3 Year Est. Return
+96.29%
5 Year Est. Return
+26.97%
10 Year Est. Return
+345.77%
AUM
$104M
AUM Growth
+$3.62M
(+3.6%)
Cap. Flow
-$109K
Cap. Flow % of AUM
Cap. Flow %
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
83.52%
Holding
39
New
3
Increased
2
Reduced
7
Closed
2
Avg Time Held
4.2
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Figma
FIG
|
+$994K |
| 2 |
Heartflow Inc
HTFL
|
+$539K |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$507K |
| 4 |
Klaviyo
KVYO
|
+$140K |
| 5 |
Viking Therapeutics
VKTX
|
+$126K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Okta
OKTA
|
+$570K |
| 2 |
Intuitive Surgical
ISRG
|
+$432K |
| 3 |
Natera
NTRA
|
+$324K |
| 4 |
Novo Nordisk
NVO
|
+$259K |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$204K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 49.28% |
| 2 | Miscellaneous | 38.94% |
| 3 | Healthcare | 10.81% |
| 4 | Financials | 0.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
iShares MSCI ACWI ETF
ACWI
$32.9B
| $40.6M | 38.94% |
293,679
| – | – |
2023 Q1
10 quarters
|
|
2
CrowdStrike
CRWD
$271B
| $15.9M | 15.27% |
129,856
-1,400
| -1% | -$159K |
2019 Q2
25 quarters
|
|
3
UiPath
PATH
$7.36B
| $13.5M | 12.96% |
1,009,684
| – | – |
2021 Q2
17 quarters
|
|
4
NVIDIA
NVDA
$5.24T
| $3.66M | 3.51% |
19,610
-700
| -3% | -$122K |
2020 Q1
22 quarters
|
|
5
Uber
UBER
$134B
| $2.88M | 2.76% |
29,354
| – | – |
2023 Q1
10 quarters
|
|
|
6
Natera
NTRA
$62.1B
| $2.54M | 2.44% |
15,788
-2,050
| -11% | -$324K |
2017 Q3
32 quarters
|
|
7
Zscaler
ZS
$41.9B
| $2.5M | 2.4% |
8,359
| – | – |
2018 Q4
27 quarters
|
|
8
Cloudflare
NET
$114B
| $2.13M | 2.04% |
9,906
| – | – |
2024 Q2
5 quarters
|
|
|
9
Alnylam Pharmaceuticals
ALNY
$30.7B
| $1.7M | 1.63% |
3,718
-500
| -12% | -$204K |
2018 Q4
27 quarters
|
|
10
Salesforce
CRM
$199B
| $1.64M | 1.57% |
6,913
| – | – |
2020 Q3
20 quarters
|
|
11
Datadog
DDOG
$100B
| $1.44M | 1.38% |
10,100
| – | – |
2019 Q3
24 quarters
|
|
12
Samsara
IOT
$25.1B
| $1.15M | 1.11% |
30,970
| – | – |
2021 Q4
15 quarters
|
|
13
Advanced Micro Devices
AMD
$938B
| $1.15M | 1.1% |
7,098
| – | – |
2022 Q1
14 quarters
|
|
14
Snowflake
SNOW
$119B
| $1.13M | 1.08% |
4,988
| – | – |
2022 Q2
13 quarters
|
|
15
MongoDB
MDB
$31.7B
| $1.09M | 1.05% |
3,521
-600
| -15% | -$154K |
2024 Q2
5 quarters
|
|
|
16
Intuitive Surgical
ISRG
$158B
| $1.02M | 0.98% |
2,278
-900
| -28% | -$432K |
2017 Q3
32 quarters
|
|
17
Mastercard
MA
$537B
| $1.02M | 0.97% |
1,785
| – | – |
2022 Q2
13 quarters
|
|
18
Veeva Systems
VEEV
$51.3B
| $822K | 0.79% |
2,759
| – | – |
2017 Q2
33 quarters
|
|
19
ServiceNow
NOW
$155B
| $822K | 0.79% |
4,465
| – | – |
2016 Q4
35 quarters
|
|
|
20
Figma
FIG
$12.3B
| $751K | 0.72% |
+14,478
| New | +$994K |
2025 Q3
0 quarters
|
|
21
Guardant Health
GH
$24.9B
| $639K | 0.61% |
10,233
| – | – |
2018 Q4
27 quarters
|
|
22
Twist Bioscience
TWST
$11.5B
| $590K | 0.57% |
20,970
| – | – |
2018 Q4
27 quarters
|
|
|
23
Heartflow Inc
HTFL
$5.12B
| $565K | 0.54% |
+16,774
| New | +$539K |
2025 Q3
0 quarters
|
|
|
RNAM
24
DELISTED
Avidity Biosciences
RNAM
| $546K | 0.52% |
+12,540
| New | +$507K |
2025 Q3
0 quarters
|
|
25
Eli Lilly
LLY
$1.15T
| $532K | 0.51% |
697
| – | – |
2024 Q2
5 quarters
|
|
Similar funds
OPL
LAMC
Brandywine Managers's Q3 2025 Portfolio in Review
As of Q3 2025, Brandywine Managers held 39 positions worth $104M, up 3.6% from $101M the previous quarter. Its ten largest holdings account for 84% of the portfolio.
Brandywine Managers's Q3 2025 filing shows 3 new, 2 increased, 7 reduced and 2 closed positions. Its largest new stake was Figma: 14,478 shares worth $751K. The largest sale was Okta, an estimated $570K.
By sector, the portfolio is most concentrated in Technology at 49% of assets, down from 51% a quarter earlier, followed by Miscellaneous and Healthcare.
- Brandywine Managers's largest Q3 2025 buy was Figma: 14,478 shares worth $751K.
- Brandywine Managers added most to Klaviyo in Q3 2025, an estimated $140K increase.
- Brandywine Managers's biggest Q3 2025 reduction was Okta, cutting an estimated $570K.
- Brandywine Managers fully exited Novo Nordisk in Q3 2025, selling an estimated $259K.
- Brandywine Managers's ten largest holdings make up 84% of its $104M portfolio in Q3 2025.
- Brandywine Managers opened 3 new positions and closed 2 in Q3 2025.
- Brandywine Managers's portfolio value rose 3.6% quarter-over-quarter to $104M.
Based on Brandywine Managers's 13F filing for Q3 2025, filed 14 Nov 2025.